Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Gaudy

Showing results (1-10 of 74) with videos related to

Pageof 8
Sort By:
Annales De Dermatologie Et De Venereologie|January 2, 2008
[Other immunosuppressants: azathioprine (Imurel), mycophenolate mofetil (Cellcept), cyclophosphamide (Endoxan)]C Gaudy-Marqueste
Annales De Dermatologie Et De Venereologie|February 9, 2020
Quoi de neuf en oncodermatologie ?C Gaudy-Marqueste
Virologie (Montrouge, France)|October 23, 2021
[The genetic diversity of hepatitis C virus and its implications for pathogenesis and resistance to treatment]C Gaudy, A Goudeau
Semaine Des Hopitaux. Therapeutique|February 1, 1976
[Long-term study of exercise tolerance in angina patients treated with perhexiline]M Gaudy, M C Gaudy
Annales De Dermatologie Et De Venereologie|January 2, 2008
[Interferon: IntronA, Roferon]C Gaudy-Marqueste, J-J Grob
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|March 2, 2015
[Prophylaxis of mother-to-infant transmission of hepatitis B virus]Y Bacq, C Gaudy-Graffin, S Marchand
Semaine Des Hopitaux. Therapeutique|September 1, 1974
[Perhexiline maleate and exercise tolerance in coronary patients]M Audier, M Gaudy, M C Gaudy
Annales De Dermatologie Et De Venereologie|July 1, 2005
[Anti-H1 in dermatological practice]C Gaudy-Marqueste, J-J Grob, M-A Richard
Applied and Environmental Microbiology|May 1, 1992
Lactococcus lactis release from calcium alginate beadsC P Champagne, C Gaudy, D Poncelet, et al.
Pathologie-Biologie|November 9, 2004
[Mutation analysis of ISDR and V3 domains of hepatitis C virus NS5A region before interferon therapy with or without ribavirin]P Veillon, C Payan, C Gaudy, et al.
Pageof 8

Showing results (1-10 of 74) with videos related to

Sort By:
Pageof 8
Annales De Dermatologie Et De Venereologie|January 2, 2008
[Other immunosuppressants: azathioprine (Imurel), mycophenolate mofetil (Cellcept), cyclophosphamide (Endoxan)]C Gaudy-Marqueste
Annales De Dermatologie Et De Venereologie|February 9, 2020
Quoi de neuf en oncodermatologie ?C Gaudy-Marqueste
Virologie (Montrouge, France)|October 23, 2021
[The genetic diversity of hepatitis C virus and its implications for pathogenesis and resistance to treatment]C Gaudy, A Goudeau
Semaine Des Hopitaux. Therapeutique|February 1, 1976
[Long-term study of exercise tolerance in angina patients treated with perhexiline]M Gaudy, M C Gaudy
Annales De Dermatologie Et De Venereologie|January 2, 2008
[Interferon: IntronA, Roferon]C Gaudy-Marqueste, J-J Grob
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|March 2, 2015
[Prophylaxis of mother-to-infant transmission of hepatitis B virus]Y Bacq, C Gaudy-Graffin, S Marchand
Semaine Des Hopitaux. Therapeutique|September 1, 1974
[Perhexiline maleate and exercise tolerance in coronary patients]M Audier, M Gaudy, M C Gaudy
Annales De Dermatologie Et De Venereologie|July 1, 2005
[Anti-H1 in dermatological practice]C Gaudy-Marqueste, J-J Grob, M-A Richard
Applied and Environmental Microbiology|May 1, 1992
Lactococcus lactis release from calcium alginate beadsC P Champagne, C Gaudy, D Poncelet, et al.
Pathologie-Biologie|November 9, 2004
[Mutation analysis of ISDR and V3 domains of hepatitis C virus NS5A region before interferon therapy with or without ribavirin]P Veillon, C Payan, C Gaudy, et al.
Pageof 8